Novartis and The Max Foundation to provide cancer access programme in lower-income countries

Novartis has entered a new collaboration with The Max Foundation to support continued access to treatment free of charge for almost 34,000 patients suffering from chronic myeloid leukaemia (CML), gastrointestinal tumours (GIST) and other rare cancers …
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news